Superficial Basal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Superficial Basal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-01-26FDA Approved: IMIQUIMOD — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's Imiquimod as an Original Application (generic) product. It covers actinic keratosis, superficial basal…
-
FDA approval · 2012-03-06FDA Approved: IMIQUIMOD — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's generic imiquimod 5% cream (ANDA 201994) as an original application, expanding access to the dermatology indications…